AzTrials
AzTrials

Asthma in ChildrenNCT03099902

Secondhand Smoking in Asthmatic Children

An observational study of Asthma in Children and Wheezing, run by AHEPA University Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will investigate the interaction between GSTP1 / TNFa polymorphisms and passive smoking in children with asthma/wheezing. Contemporary second hand-smoke exposure will be confirmed by laboratory testing. Read more about this study

Who is it for?
Ages 12 months to 18 yearsHealthy volunteers can take part
Conditions the study is for
Asthma in Children, Wheezing
What is being tested?
Lung function, White blood cell DNA extraction and Urinary testing
How many people
90 participants
Where
No sites listed yet
Study dates
1 Nov 2010to 1 Sep 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 months to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Subjects attending the Pediatric Outpatient Clinic

Who may be able to join

  • Subjects 1-18 years old with doctor diagnosed asthma/wheezing

Who cannot join

  • Premature birth (< 36 gestation weeks)
  • Asthma-like symptoms due to other conditions (infectious, congenital, mechanical)

About this study

Official title: Association Between Maternal Smoking and GSTP1 and TNFa Polymorphism in Children With Asthma/Wheezing

This study will investigate the interaction between GSTP1 / TNFa polymorphisms and passive smoking in children with asthma/wheezing. Contemporary second hand-smoke exposure will be confirmed by laboratory testing.

Being tested
Lung function, White blood cell DNA extraction, Urinary testing
Keywords
Asthma, Wheezing, GSTP1, TNFa, Secondhand smoking, Passive smoking, Intrauterine smoking
Medical subject headings
Respiratory Sounds, Asthma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lung functionDiagnostic test

    Spirometry test

  • White blood cell DNA extractionDiagnostic test

    GSTP1 and TNFa polymorphisms with PCR

  • Urinary testingDiagnostic test

    Urinary nicotine and cotinine detection

Study groups in NCT03099902
Study groupRoleWhat they receive
CasesChildren with asthma/wheezing whose mothers were active smokers during pregnancy
Receives: Diagnostic Test: Lung function; Diagnostic Test: White blood cell DNA extraction; Diagnostic Test: Urinary testing
ControlsChildren without asthma/wheezing whose mothers were active smokers during pregnancy
Receives: Diagnostic Test: Lung function; Diagnostic Test: White blood cell DNA extraction; Diagnostic Test: Urinary testing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. GSTP1 and TNFa variants in children with asthma

    Measured: 0 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2017
  2. Study start1 Nov 2010
  3. Primary completion1 Sep 2015
  4. Study completion1 Sep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03099902
Sponsor's protocol ID
14/1-3-2011
Status last verified
Apr 2017
First submitted
22 Mar 2017
Last updated
11 Apr 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Asthma in Children and Wheezing, run by AHEPA University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

GSTP1 and TNFa variants in children with asthma (time frame: 0 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in